AND 4.55% $1.04 ansarada group limited

atl1103: trial update - safe and expanded

  1. 619 Posts.
    ? 16 patients now in the trial
    ? Data Safety Monitoring Board recommended study continue unchanged on review
    of safety data
    ? Ethics approvals received for the initiation of 2 trial sites in Australia
    ? Interim analysis results on track for reporting by end 2013

    Looking very good IMO. Nice to get this level of comfort before the interim results which are still on track.
    Look at us compared to the other Bios running hard lately. I know where I'm putting my hard earned. The upside for us is significant in comparison.
    But I've got my fingers in many bio pies so happy for the sector to run...
 
watchlist Created with Sketch. Add AND (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.